
    
      This study is a multiple ascending dose study to Assess the Safety, Tolerability, and
      Pharmacokinetics of orally dosed PG 760564 Administered Twice Daily to Healthy Male and
      Female Volunteers for 14 Days (27 Doses). The study is a multiple rising dose (MRD) study of
      active drug vs. placebo.
    
  